Free Trial
OTCMKTS:CPMV

Mosaic ImmunoEngineering (CPMV) Stock Price, News & Analysis

Mosaic ImmunoEngineering logo
$0.82
0.00 (0.00%)
(As of 10/31/2024 ET)

About Mosaic ImmunoEngineering Stock (OTCMKTS:CPMV)

Key Stats

Today's Range
$0.82
$0.82
50-Day Range
$0.64
$1.03
52-Week Range
$0.10
$1.13
Volume
N/A
Average Volume
982 shs
Market Capitalization
$5.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals. The company was founded in 2020 and is based in Novato, California.

Receive CPMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mosaic ImmunoEngineering and its competitors with MarketBeat's FREE daily newsletter.

CPMV Stock News Headlines

The most productive 1 min of your day…
This next step in your trading career is a simple, yet important one. I want you to take 1 minute to sign up for FREE algo alerts powered by StocksToTrade.
Mosaic ImmunoEngineering Inc Ordinary Shares CPMV
See More Headlines

CPMV Stock Analysis - Frequently Asked Questions

Mosaic ImmunoEngineering's stock was trading at $0.60 at the beginning of 2024. Since then, CPMV stock has increased by 36.5% and is now trading at $0.8190.
View the best growth stocks for 2024 here
.

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) issued its earnings results on Wednesday, August, 14th. The company reported ($0.04) EPS for the quarter.

Shares of CPMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mosaic ImmunoEngineering investors own include BioNxt Solutions (BNXTF), Defense Metals (DFMTF), C3.ai (AI), Applied Genetic Technologies (AGTC), Agile Therapeutics (AGRX), AgriFORCE Growing Systems (AGRI) and Aeva Technologies (AEVA).

Company Calendar

Last Earnings
8/14/2024
Today
10/31/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CPMV
Employees
3
Year Founded
N/A

Profitability

Net Income
$-1,010,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.81) per share

Miscellaneous

Free Float
1,377,000
Market Cap
$5.93 million
Optionable
Not Optionable
Beta
-0.01
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:CPMV) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners